METASTATIC SOLID TUMOR
Clinical trials for METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested in fight against advanced cancers
Disease control TerminatedThis early-stage study tested a new drug called BGB-A3055, both alone and combined with another cancer drug (tislelizumab), in people with advanced solid tumors that had spread. The main goals were to find a safe dose and see if the treatment showed early signs of fighting the ca…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Tumor-Injected drug aims to rally immune system against cancer
Disease control TerminatedThis early-stage study tested a new drug designed to stimulate the immune system to fight cancer. The drug was injected directly into tumors, either by itself or combined with an existing immunotherapy (pembrolizumab), in people with advanced solid tumors. The main goals were to …
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Early-Stop cancer trial tests novel drug duo for tough tumors
Disease control TerminatedThis study tested the safety and effectiveness of a new drug, PRT3789, combined with an existing immunotherapy (pembrolizumab) for people with advanced solid tumors that have a specific genetic change called a SMARCA4 mutation. The trial was designed for patients whose cancer had…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
First human test of new Cancer-Fighting antibody begins
Disease control TerminatedThis is an early-stage study to test the safety and find the right dose of a new drug called BGB-B3227 for people with advanced or metastatic solid tumors. The drug will be tested both by itself and in combination with another cancer drug, tislelizumab. The main goals are to see …
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New pill targets genetic weakness in advanced cancers
Disease control TerminatedThis early-stage study tested a new oral drug called PRT7732 in people with advanced or metastatic solid tumors that have a specific genetic change (SMARCA4 mutation). The main goals were to find a safe dose, see how the body processes the drug, and look for early signs that it m…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC